Relation of Fibrinogen-to-Albumin Ratio to Severity of Coronary Artery Disease and Long-Term Prognosis in Patients with Non-ST Elevation Acute Coronary Syndrome
Table 4
Univariate and multivariate Cox regression analysis for predictors of MACE.
Univariate analysis
Multivariate analysis
HR
95% CI
value
HR
95% CI
value
30-day MACE
Female
0.407
0.210~0.787
0.008
0.442
0.227~0.858
0.016
BMI
1.143
1.060~1.232
<0.001
1.148
1.061~1.242
0.001
NSTEMI
3.024
1.779~5.142
<0.001
2.235
1.256~3.980
0.006
TnI
1.040
0.970~1.115
0.268
CK-MB
1.009
1.004~1.014
0.001
1.005
1.000~1.011
0.064
FAR
1.142
1.050~1.243
0.002
1.095
1.011~1.186
0.025
6-month MACE
BMI
1.087
1.025~1.152
0.005
1.082
1.019~1.149
0.010
NSTEMI
3.065
2.058~4.564
<0.001
2.544
1.678~3.856
<0.001
TnI
1.050
1.003~1.099
0.038
0.984
0.914~1.060
0.675
CK-MB
1.008
1.003~1.013
0.002
1.004
0.997~1.010
0.241
FAR
1.120
1.047~1.197
0.001
1.076
1.009~1.147
0.026
1-year MACE
BMI
1.059
1.009~1.112
0.020
1.061
1.010~1.115
0.018
NSTEMI
2.472
1.773~3.448
<0.001
2.001
1.392~2.878
<0.001
TnI
1.042
1.000~1.086
0.049
0.979
0.915~1.048
0.546
CK-MB
1.008
1.004~1.012
<0.001
1.005
1.000~1.010
0.050
FAR
1.113
1.053~1.177
<0.001
1.080
1.022~1.141
0.006
MACE: major adverse cardiovascular event; BMI: body mass index; NSTEMI: non-ST elevation myocardial infarction; TnI: troponin I; CK-MB: creatine kinase-MB; FAR: fibrinogen-to-albumin ratio.
